文献速递生殖医学

使用捐赠卵母细胞的新鲜或冷冻胚胎移植后出生儿童的围产期结局

Perinatal outcomes in children born after fresh or frozen embryo transfer using donated oocytes.
PubMed 文献 · Hum Reprod · 2022-01-01

多中心回顾性队列研究纳入2009年至2020年2月期间经捐赠卵母细胞单囊胚移植后出生的5848例单胎,比较新鲜胚胎移植与冻融胚胎移植的围产期结局。主要结局出生体重在两组间无显著差异(3215 g vs 3200 g),早产率亦无显著差异(9.9% vs 11.2%)。人工子宫内膜准备与自然周期相比与更高出生体重相关(3220 g vs 3105 g)。

要点

  • 捐赠卵母细胞模型中,新鲜与冻融胚胎移植的单胎出生体重无显著差异(3215 g vs 3200 g)。
  • 两组早产率(<37周)无显著差异,分别为9.9%和11.2%。
  • 人工子宫内膜准备较自然周期与更高出生体重相关(3220 g vs 3105 g)。

核心结论

  • 在捐赠卵母细胞模型中,胚胎玻璃化冷冻过程似乎未对围产期结局产生显著影响。
  • 其他因素可能促成辅助生殖技术中描述的围产期结局受损,尤其是卵巢刺激和子宫内膜准备对子宫内膜容受性的潜在影响。

研究设计与样本

  • 多中心回顾性队列研究,纳入2009年至2020年2月期间经捐赠卵母细胞和单囊胚移植后出生的5848例单胎,按新鲜胚胎移植或冻融胚胎移植分组。
  • 另进行两项敏感性分析,分别按子宫内膜准备类型(自然周期与人工周期)及捐赠卵母细胞是否曾经历玻璃化冷冻进行亚组分析。
  • 纳入首次单胎活产患者,采用多变量回归分析校正潜在混杂因素。

主要发现

  • 新鲜胚胎移植组与冻融胚胎移植组平均出生体重分别为3215 g和3200 g,出生体重z评分分别为0.03和0.1,未校正和校正混杂因素模型中均无显著差异。
  • 人工子宫内膜准备组与自然周期组相比,出生体重分别为3220 g和3105 g,出生体重z评分分别为0.06和-0.13,人工准备组更高。
  • 分娩时孕龄在两组间存在1天的统计学显著差异(275天 vs 274天),但早产率(<37周)无显著差异(新鲜移植组9.9%,冻融移植组11.2%)。
  • 其余新生儿和母体结局在新鲜胚胎移植组与冻融胚胎移植组间未发现其他统计学显著差异。

局限性

  • 研究受限于回顾性设计。
  • 缺乏先天性畸形信息。
  • 样本选择标准可能限制结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do children born after vitrified-thawed embryo transfers (ETs) using donated oocytes have worse perinatal outcomes when compared with fresh ET? SUMMARY ANSWER: No significant difference in birthweight and prematurity rates between fresh or frozen embryo transfers (FETs) in newborns after oocyte donation was found. WHAT IS KNOWN ALREADY: Autologous singletons born after fresh ET have been previously associated with higher rates of preterm birth and low birthweight, while FETs seem to confer a higher risk of hypertensive disorders during pregnancy and macrosomia. However, studies comparing these outcomes using autologous oocytes are unable to adequately disentangle the putative detrimental consequences of embryo vitrification from the possible effects that ovarian stimulation and endometrial preparation may have on endometrial receptivity prior to ET. The oocyte donation model is, for this reason, a more appropriate setting to study these hypotheses; however so far, the information available regarding neonatal outcomes in this patient population is limited to either small and/or heterogeneous studies. STUDY DESIGN, SIZE, DURATION: We performed a multicentre retrospective cohort study including 5848 singletons born between 2009 and February 2020 following oocyte donation and single blastocyst transfer, subdivided according to whether a fresh ET or FET was performed. We also performed two additional sensitivity analyses, subgrouping the sample according to the type of endometrial preparation (natural versus artificial) and whether the donated oocytes had previously been vitrified or not. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients with a first singleton livebirth after single blastocyst transfer were compared using multivariable regression analysis to account for potential confounding factors. The primary outcome was birthweight. Secondary outcomes were birthweight z-scores and percentiles, small/large for gestational age, gestational age at delivery, gender, prematurity (<37 weeks and <32 weeks), neonatal morbidity (Apgar scores and need for neonatal intensive care) and maternal morbidity (gestational hypertensive disorders, gestational diabetes and caesarean delivery). MAIN RESULTS AND THE ROLE OF CHANCE: There was no significant difference between the fresh ET and FET groups in terms of mean birthweight (3215 g versus 3200 g) and birthweight z-scores (0.03 versus 0.1), in both the unadjusted and confounder-adjusted models. However, artificial endometrial preparation was associated with a higher birthweight (3220 g versus 3105 g) and birthweight z-scores (0.06 versus -0.13) when compared with a transfer in a natural cycle. Although a 1-day statistically significant difference in gestational age at birth (275 versus 274 days) was detected, premature birth rates (<37 weeks) did not vary significantly between groups (9.9% and 11.2% for fresh ET and FET, respectively). No other statistically significant differences were found in the remaining neonatal and maternal outcomes studies between the fresh ET and FET groups. LIMITATIONS, REASONS FOR CAUTION: This study is limited by its retrospective design and lack of information regarding congenital malformations. Moreover, the sample selection criteria that were used may limit the generalizability of our results. WIDER IMPLICATIONS OF THE FINDINGS: Perinatal outcomes did not seem to be affected significantly by the embryo vitrification process in an oocyte donation model. Hence, other factors may contribute to the hindered perinatal outcomes described in ART, particularly the potential effect that ovarian stimulation and endometrial preparation may have on endometrial receptivity. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was obtained for this study. All authors have no conflicts to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Rafael F, Robles GM, Navarro AT, et al. Perinatal outcomes in children born after fresh or frozen embryo transfer using donated oocytes. Hum Reprod. 2022. PMID: 35451027. doi:10.1093/humrep/deac074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。